Quantcast

Latest Gallus BioPharmaceuticals LLC Stories

2014-04-29 23:22:06

Gallus BioPharmaceuticals, a premier pure-play biologics contract development and manufacturing organization and Omni Bio Pharmaceutical, a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT), jointly announced finalization of a multi-stage manufacturing services agreement. St. Louis, Missouri (PRWEB) April 29, 2014 Gallus BioPharmaceuticals, LLC(Gallus), a premier pure-play biologics contract development and manufacturing...

2014-02-25 23:36:32

Gallus BioPharmaceuticals, LLC, a premier pure-play biologics contract manufacturing organization has signed a manufacturing agreement with Symphogen, A/S, a private biopharmaceutical company developing recombinant monoclonal antibody mixtures for the treatment of cancer. St. Louis, Missouri (PRWEB) February 25, 2014 Gallus BioPharmaceuticals, LLC (Gallus), a premier pure-play biologics contract manufacturing organization (CMO) has signed a manufacturing agreement with Symphogen, A/S...

2014-02-11 23:31:22

Gallus BioPharmaceuticals, LLC, a premier pure-play biologics contract manufacturing organization announces the appointment of Claudette Kile as Vice President of Quality & Regulatory. St. Louis, MO (PRWEB) February 11, 2014 Gallus BioPharmaceuticals, LLC (Gallus), a premier pure-play biologics contract manufacturing organization (CMO) announces the appointment of Claudette Kile as Vice President of Quality & Regulatory. This addition to the highly experienced Gallus leadership...

2014-01-29 23:35:14

Gallus BioPharmaceuticals, a premier pure-play biologics contract manufacturing organization, has completed a second expansion of its Process Development facility at its headquarters in St. Louis, Missouri. This expansion provides additional laboratory space and state-of-the-art instrumentation to support Gallus’ growth and commitment to leading pharma and biotech clients in the development of new biotherapeutics. St. Louis, Missouri (PRWEB) January 29, 2014 Gallus BioPharmaceuticals,...

2013-10-01 23:31:39

Gallus BioPharmaceuticals, LLC, a leading biologics contract manufacturing organization, today announced its acquisition of Laureate Biopharmaceutical Services, Inc., a full service biologics CMO located in Princeton, New Jersey. This acquisition doubles Gallus’ process development (PD) and clinical drug substance manufacturing capacity, adds full protein characterization, testing and clinical fill-finish capability and offers a seamless development pathway for clients - from early stage...

2013-07-31 23:26:40

As part of the multi-year agreement Gallus will provide process and method development, scale-up, clinical supply and preparation for commercial manufacturing for an infused protein-based therapy targeting the rare disease, Niemann-Pick type B. St. Louis, Missouri (PRWEB) July 31, 2013 Gallus Biopharmaceuticals, LLC (Gallus) has signed a development and manufacturing supply agreement with Genzyme, a Sanofi Company the pioneer in the development and delivery of transformative therapies for...

2012-12-06 05:02:25

Experienced Commercial Leader To Drive Continued Fast Growth at World-Class CMO. (PRWEB) December 05, 2012 Gallus BioPharmaceuticals, LLC (Gallus) announced that Mr. Joseph (Joe) Coffey has joined the company as Chief Commercial Officer to lead the sales and marketing organizations. Joe joins Gallus at a time of accelerating growth following completion of a $20 million expansion which added development, clinical and commercial manufacturing contract services for bulk biopharmaceuticals....

2012-09-18 23:00:18

Gallus BioPharmaceuticals, LLC (Gallus)–a leading provider of contract services to biopharmaceutical companies – announced today a collaboration agreement with Roslin Cells Ltd. (Roslin Cells), based in Edinburgh, Scotland, to develop and supply clinical and commercial cell therapy products. (PRWEB) September 18, 2012 In this partnership, Gallus will provide process development, clinical and commercial supply for cell therapy-based biopharmaceutical products to Roslin...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.